NFKB1 and colitis: In our study, DSF+Cu2+ inhibited the activity of NF-κB in DSS-induced colitis and LPS-induced peritoneal macrophages, J774A.1, THP-1, and BMDMs, resulting in down-regulation of proinflammatory factors.